Oral administration of interferon-α2b-transformed <it>Bifidobacterium longum </it>protects BALB/c mice against coxsackievirus B3-induced myocarditis
<p>Abstract</p> <p>Multiple reports have claimed that low-dose orally administered interferon (IFN)-α is beneficial in the treatment of many infectious diseases and provides a viable alternative to high-dose intramuscular treatment. However, research is needed on how to express IFN...
Main Authors: | Yu Zhijian, Huang Zhen, Shao Chongwen, Huang Yuanjian, Zhang Fan, Yang Jin, Deng Lili, Zeng Zhongming, Deng Qiwen, Zeng Weiseng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | http://www.virologyj.com/content/8/1/525 |
Similar Items
-
Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes
by: Soo-Hyeon Yun, et al.
Published: (2020-04-01) -
Development of antiviral therapeutics combating coxsackievirus type B3 infection
by: A. S. Volobueva, et al.
Published: (2021-02-01) -
Melatonin Ameliorates Coxsackievirus B3-Induced Myocarditis by Regulating Apoptosis and Autophagy
by: Yimiao Sang, et al.
Published: (2018-12-01) -
Murine model of acute myocarditis and cerebral cortical neuron edema induced by coxsackievirus B4
by: Zhao-Peng Dong, et al.
Published: (2018-01-01) -
Opioid-Induced Immunomodulation: Consequences for the Experimental Coxsackievirus B3-Induced Myocarditis Model
by: Kathleen Pappritz, et al.
Published: (2020-10-01)